Home
Live Updates
FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer : comparemela.com
FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer
PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.
Related Keywords
United States ,
Ming Wang ,
Phanes Therapeutics Inc ,
Phanes Therapeutics ,
Patients With ,
Advanced Gastric ,
Gastroesophageal Junction ,
Fast Track ,
Therapeutics Announces First Patient Dosed ,
Announces Clinical Trial Collaboration ,
Supply Agreement ,
comparemela.com © 2020. All Rights Reserved.